CVS Health Corp (NYSE:CVS)
| 72.56 BATS BZX Real-Time Price As of 11:28am ET |  -1.56 / -2.10%Today’s Change | 52.04 Today|||52-Week Range 77.23 | +6.24% Year-to-Date |
CVS Regular Dividend: CVS began trading ex-dividend on 01/21/21. A $0.50 dividend will be paid to shareholders of record as of 01/22/21.
Latest CVS News | Press Releases
| 3 Top Stocks to Recession-Proof Your Portfolio Jan 22 / MotleyFool.com - Paid Partner Content | 3 Healthcare Stocks That Could Make You Rich Jan 21 / MotleyFool.com - Paid Partner Content |
| Walmart will expand Covid-19 vaccinations to more states Jan 22 / CNN.com - Paid Partner Content | Does This Recent News Make Walgreens a Better Buy? Jan 21 / MotleyFool.com - Paid Partner Content |
| Is CVS Health a Great Dividend Stock? Jan 22 / MotleyFool.com - Paid Partner Content | 2 Top Value Stocks To Buy Right Now Jan 20 / MotleyFool.com - Paid Partner Content |
| 3 Top Coronavirus Stocks to Buy Now Jan 22 / MotleyFool.com - Paid Partner Content | The T Rowe Price Equity Income Fund Cuts Qualcomm, Fox Jan 20 / GuruFocus News - Paid Partner Content |
| CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know Jan 21 / Zacks.com - Paid Partner Content | 2 Value Stocks to Consider Buying if the Market Sells-Off: CVS Health and Allstate Jan 19 / StockNews.com - Paid Partner Content |
Today’s Trading
| Previous close | 74.12 |
| Today’s open | 73.50 |
| Day’s range | 72.33 - 73.53 |
| Volume | 3,049,987 |
| Average volume (3 months) | 8,208,483 |
| Market cap | $97.0B |
Data as of 11:28am ET, 01/25/2021
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +5.16% |
| Earnings growth (next 5 years) | +3.59% |
| Revenue growth (last year) | +31.86% |
| P/E ratio | 12.0 |
| Price/Sales | 0.38 |
| Price/Book | 1.51 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WBAWalgreen | -0.50 | -1.05% |
| RADRite Aid Corp | +2.13 | +10.77% |
| YI111 Inc | +0.23 | +1.92% |
| PETSPetmed Express Inc | +5.06 | +16.38% |
Data as of 11:27am ET, 01/25/2021
Financials
| Next reporting date | February 16, 2021 |
| EPS forecast (this quarter) | $1.24 |
| Annual revenue (last year) | $256.6B |
| Annual profit (last year) | $6.6B |
| Net profit margin | 2.58% |
Profile
Sector Retail Trade |
Industry Drugstore Chains |
No executives to display |
Corporate headquarters Woonsocket, Rhode Island |
Forecasts
